Related Experiment Video
Updated: May 14, 2026

Sample Preparation for Mass Spectrometry-based Identification of RNA-binding Regions
Published on: September 28, 2017
Structure of the Cmr2-Cmr3 subcomplex of the Cmr RNA silencing complex
Yaming Shao1, Alexis I Cocozaki, Nancy F Ramia
1Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306, USA.
Abstract:
The Cmr complex is an RNA-guided effector complex that cleaves invader RNA in the prokaryotic immune response mediated by the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat)-Cas system. Here, we report the crystal structure of a Cmr subcomplex containing Cmr2 (Cas10) and Cmr3 subunits at 2.8 Å resolution. The structure revealed a dual ferredoxin fold and glycine-rich loops characteristic of previously known repeat-associated mysterious proteins and two unique insertion elements in Cmr3 that mediate its interaction with Cmr2. Surprisingly, while mutation of both insertion elements significantly weakened Cmr3-Cmr2 interaction, they exhibit differential effects on Cmr-mediated RNA cleavage by the Cmr complex, suggesting stabilization of Cmr2-Cmr3 interactions by other subunits. Further mutational analysis of the two conserved (but non-Cmr2-binding) glycine-rich loops of Cmr3 identified a region that is likely involved in assembly or the RNA cleavage function of the Cmr complex.
Insights
Researchers elucidated the crystal structure of a CRISPR-associated (Cas) Cmr subcomplex, revealing key interactions between Cmr2 and Cmr3 subunits. This structural insight aids understanding of prokaryotic RNA-guided immunity mechanisms.
Area of Science:
- Molecular Biology
- Structural Biology
- Microbiology
Background:
- The CRISPR-Cas system provides adaptive immunity in prokaryotes by targeting and cleaving foreign nucleic acids.
- The Cmr complex is a key RNA-guided effector complex within the CRISPR-Cas system, responsible for degrading invading RNA.
- Understanding the structural basis of Cmr complex function is crucial for elucidating prokaryotic defense mechanisms.
Purpose of the Study:
- To determine the crystal structure of a Cmr subcomplex composed of Cmr2 (Cas10) and Cmr3 subunits.
- To investigate the molecular interactions between Cmr2 and Cmr3 subunits.
- To identify regions within Cmr3 involved in Cmr complex assembly and RNA cleavage activity.
Main Methods:
- X-ray crystallography was employed to obtain the 2.8 Å resolution structure of the Cmr2-Cmr3 subcomplex.
- Site-directed mutagenesis was used to probe the function of specific Cmr3 domains and loops.
- Analysis of RNA cleavage activity was performed to assess the functional impact of mutations.
Main Results:
- The crystal structure revealed a dual ferredoxin fold and glycine-rich loops in Cmr3, alongside two unique insertion elements mediating Cmr2 interaction.
- Mutations in Cmr3 insertion elements weakened the Cmr2-Cmr3 interaction but had differential effects on RNA cleavage, suggesting roles for other subunits.
- Mutational analysis of conserved glycine-rich loops in Cmr3 identified a region potentially involved in Cmr complex assembly or RNA cleavage.
Conclusions:
- The structure provides a detailed molecular basis for Cmr2-Cmr3 interactions within the Cmr complex.
- The findings highlight the complex interplay of subunits in regulating Cmr complex function and RNA cleavage.
- This study identifies novel functional regions in Cmr3, advancing our understanding of CRISPR-Cas RNA-guided immunity.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Cis-regulatory Sequences
Cis-regulatory Sequences
Experimental RNAi
Cooperative Binding of Transcription Regulators
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

